The resignation of Peter Marks, a critical figure at the FDA overseeing vaccine regulation, acts as an unsettling signal for the future of immunization policy in the United States. This development raises many red flags, particularly in the context of the Trump administration’s controversial policies regarding public health. Marks’ departure over his opposition to Health
Kathryn Glass’s journey into the finance world is nothing short of captivating. With an educational background rooted deeply in Japanese language and literature — including a bachelor’s from the University of Pittsburgh and a master’s from Cornell — her initial career trajectory was far removed from the financial realm. It’s striking how a life pivot
Tax exemptions for municipal bonds have been a crucial pillar supporting public services across America, particularly in the domains of utilities and infrastructure. The suggestion proposed by congressional Republicans to eliminate this tax exemption poses not only a fiscal conundrum but threatens the very fabric of public welfare. By stripping municipal bonds of their tax-exempt
When Wes Moore, the Governor of Maryland, was merely eight years old, his mother considered the unlikely option of sending him to military school as a corrective measure. At the age of 13, that plan bore fruit, leading him to a school in Pennsylvania, albeit after a rocky start marked by multiple escape attempts. His
The current economic climate has been tumultuous, influenced heavily by the lingering effects of tariffs imposed during the Trump era. Concerns over demand dampen investor sentiment and raise fears of a looming recession, resulting in a turbulent stock market landscape. However, amid this chaos, discerning investors can find hidden gems trading at depressed valuations yet
China’s consumer market has long been recognized as one of the most vital engines of its economic growth. However, since the pandemic’s onset, this engine has sputtered with an unsettling reluctance to rekindle spending habits. The growth of retail sales has plummeted to a mere 3.5% last year—a staggering difference compared to an impressive 9.7%
In a startling revelation, Novo Nordisk’s diabetes medication Rybelsus has demonstrated a noteworthy 14% reduction in the risk of cardiovascular-related death, heart attack, and stroke. This groundbreaking data emerged from a comprehensive late-stage trial presented at the American College of Cardiology’s Annual Scientific Session in Chicago. The implications are significant for the diabetic population, particularly
Investing in the stock market today feels akin to walking a tightrope during a storm; uncertainty looms large and the winds of inflation and trade tensions threaten to knock even the most seasoned investors off balance. Recent months have presented a puzzle for those in the market, with alarming economic indicators clashing against rosy forecasts
At just 32, Charlie Javice seemed poised to be a prominent figure in the startup world. Her company, Frank, initially attracted attention for its ambitious goal to simplify the college financial aid process. However, the once-celebrated entrepreneur now faces serious legal repercussions for allegedly deceiving JPMorgan Chase. This case represents a deep-seated issue in the
The high-speed rail project in California, once viewed as a groundbreaking investment in infrastructure and technology, now stands on the precipice of failure. With an unsettling budget shortfall of $7 billion looming over the already beleaguered Central Valley segment, the vision of high-speed rail is starting to feel more like a mirage—a lofty goal that